Shortcomings of pertussis vaccines: why we need a third generation vaccine
Author:
- 4 August 2014
- journal article
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 13 (10) , 1159-1162
Abstract
First generation whole-cell (wP) and second generation acellular (aP) pertussis vaccines have been highly effective in preventing childhood deaths due to pertussis, yet both vaccines have drawbacks that have limited their long-term usefulness. These include issues of reactogenicity and potency in the case of wP, and limited durability of protection and the potential for selection of escape mutants in the case of aP. Neither vaccine prevents disease in neonatal infants who continue to die from pertussis. A third generation of pertussis vaccines that provides broad, durable protection is needed. In the meantime, countries using wP should continue to do so, while countries using aP need to consider policies and schedules that reduce pertussis transmission to unvaccinated infants. In this respect, maternal vaccination appears to be a promising solution.Keywords
This publication has 24 references indexed in Scilit:
- Pertussis vaccine encephalopathy: ‘Oh! Let us never, never doubt …Developmental Medicine & Child Neurology, 2010
- Toxicity and potency evaluation of pertussis vaccinesExpert Review of Vaccines, 2004
- Systematic review of the effects of pertussis vaccines in childrenVaccine, 2003
- Development of Acellular Pertussis VaccinesBiologicals, 1999
- Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines1All animal studies were conducted in accordance with the French and Belgian national legislative guidelines for animal experimentation.1Vaccine, 1999
- Estimates of the effectiveness of a whole-cell pertussis vaccine from an outbreak in an immunized populationVaccine, 1997
- Historical Review Of Pertussis And The Classical VaccineThe Journal of Infectious Diseases, 1996
- A Controlled Trial of a Two-Component Acellular, a Five-Component Acellular, and a Whole-Cell Pertussis VaccineNew England Journal of Medicine, 1996
- A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against PertussisNew England Journal of Medicine, 1996
- Mouse Protection Tests in the Study of Pertussis VaccineAmerican Journal of Public Health and the Nations Health, 1947